Targeting DNA repair defects in prostate cancer
- PMID: 32651483
- DOI: 10.1038/s41585-020-0360-6
Targeting DNA repair defects in prostate cancer
Comment on
-
Olaparib for Metastatic Castration-Resistant Prostate Cancer.N Engl J Med. 2020 May 28;382(22):2091-2102. doi: 10.1056/NEJMoa1911440. Epub 2020 Apr 28. N Engl J Med. 2020. PMID: 32343890 Clinical Trial.
References
-
- Nat Rev Clin Oncol. 2020 Aug;17(8):455-456 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
